AADE in Practice
Beyond Insulin: Novel Approaches to Treating Type 1 Diabetes
Geoffrey Twigg, PHARMD, BCACP, CDE, Benjamin Forrest, PHARMD, Lana Saad Sherr, PHARMD, BS PHARM, Haroon Amir, PHARMD CANDIDATE
First Published February 13, 2019
Managing Diabetes by Maintaining Healthier Beta Cells: A Fresh Perspective for DiabetesCare and Education Specialists
Gary Scheiner, MS, CDE, Stanley S. Schwartz, MD, FACP, FACE, Mary E. Herman, PhD
First Published June 25, 2018
Managing Adverse Effects Related to Newer Type 2 Diabetes Medications
Oluwaranti Akiyode, PharmD, BCPS, CDE
First Published October 19, 2015.
Glucagon-Like Peptide Receptor Agonists: A Viable Addition to Basal-Bolus Therapy in Type 2 Diabetes?
Tommy Johnson, PharmD, CDE, BC-ADM, FAADE, Tiffaney Threatt, PharmD, CDE, Sarah Wagner, PharmD,Eileen Ward, PharmD, BCACP
First Published December 18, 2014.
The Diabetes Educator
Understanding GLP-1 Analogs and Enhancing Patient Success
Vol. 36, 3-suppl: pp. 44S-72S. First Published August 24, 2010
Davida F. Kruger, MSN, APN-BC, BC-ADM, Bruce Bode, MD, FACE, Geralyn R. Spollett, MSN, ANP-CS, CDE
GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice
Vol. 41, 1-suppl: pp. 32S-46S. First Published October 8, 2015
Curtis Triplitt, PharmD, CDE; Carolina Solis-Herrera, MD
Complementary Approaches to Improving Glucose Control—Insulin and Incretins: Patient Case Studies in Action
Vol. 40, 1_suppl: pp. 4S-26S. First Published May 19, 2014
Jerry Meece, RPh, FACA, CDE, FAADE, Teresa L. Pearson, MS, RN, CDE, FAADE, Linda M. Siminerio,RN, PhD, CDE, FAAN